Prima BioMed Announces Data From IMP321 AIPAC Clinical Trial in Breast Cancer

Wednesday, December 21, 2016 1 min read

Key Takeaway: Prima BioMed Announces Data From IMP321 AIPAC Clinical Trial in Breast Cancer